En Es
Categories

IDL BIOTECH AB

IDL BIOTECH AB

IDL Biotech AB is a diagnostic company that develops, produces and markets IVD tests worldwide for the healthcare sector. IDL is active in the fields of Oncology and Bacteriology, manufacturing various tumor markers and a rapid Salmonella Typhoid test. IDL's products enable diagnosis and prognosis of diseases, contro ...
Products Summary
Close

About IDL BIOTECH AB

IDL Biotech AB is a diagnostic company that develops, produces and markets IVD tests worldwide for the healthcare sector. IDL is active in the fields of Oncology and Bacteriology, manufacturing various tumor markers and a rapid Salmonella Typhoid test. IDL's products enable diagnosis and prognosis of diseases, control of treatment efficiency and to prolong the interval between more invasive examinations of the patients.

Recently updated

POC Bladder Cancer Test
UBC Rapid

UBC Rapid is a powerful Doctors-office test (Point-of-Care), for both primary diagnosis and monitoring and follow-up of bladder cancer, especially for papillary non-invasive high-grade tumors and carcinoma in situ (CIS). The test specifically measures soluble fragments of cytokeratin 8 and 18 in urine samples. It can easily be performed by a nurse or a technician with minimal training and the results are obtained within 10 minutes. UBC Rapid performs better than urine cytology in many patients due to im¬proved sensitivity and the combination of UBC Rapid and cytology enables detection of additional tumors as opposed to cytology alone.
More details

NSCLC Immunoassay
MonoTotal

MonoTotal is a quantitative immunoassay and a sensitive tumor activity marker for the detection and identification of Non-Small Cell Lung Cancer (NSCLC). It specifically measures defined epitopes on cytokeratin 19, 8 and 18 to provide physicians with an early indication of disease status, measured in terms of tumor cell activity rather than more conventional tumor burden measurements.
More details

Typhoid Fever Rapid Test
TUBEX TF

TUBEX TF is a rapid and sensitive in vitro diagnostic test for detection of acute typhoid fever, a disease caused by Salmonella typhi. The test principle for TUBEX TF is based on Inhibition Magnetic Binding Immunoassay – a semi quantitative colometric assay (IMBI). The test is characterized by high sensitivity and specificity, and can be performed in any laboratory environment with the result ready within 10 minutes.
More details

Clinical Laboratory

POC Bladder Cancer Test
UBC Rapid

UBC Rapid is a powerful Doctors-office test (Point-of-Care), for both primary diagnosis and monitoring and follow-up of bladder cancer, especially for papillary non-invasive high-grade tumors and carcinoma in situ (CIS). The test specifically measures soluble fragments of cytokeratin 8 and 18 in urine samples. It can easily be performed by a nurse or a technician with minimal training and the results are obtained within 10 minutes. UBC Rapid performs better than urine cytology in many patients due to im¬proved sensitivity and the combination of UBC Rapid and cytology enables detection of additional tumors as opposed to cytology alone.
More details

NSCLC Immunoassay
MonoTotal

MonoTotal is a quantitative immunoassay and a sensitive tumor activity marker for the detection and identification of Non-Small Cell Lung Cancer (NSCLC). It specifically measures defined epitopes on cytokeratin 19, 8 and 18 to provide physicians with an early indication of disease status, measured in terms of tumor cell activity rather than more conventional tumor burden measurements.
More details

Typhoid Fever Rapid Test
TUBEX TF

TUBEX TF is a rapid and sensitive in vitro diagnostic test for detection of acute typhoid fever, a disease caused by Salmonella typhi. The test principle for TUBEX TF is based on Inhibition Magnetic Binding Immunoassay – a semi quantitative colometric assay (IMBI). The test is characterized by high sensitivity and specificity, and can be performed in any laboratory environment with the result ready within 10 minutes.
More details
Copyright © 2000-2024 TradeMed.com. All rights reserved. | Terms And Conditions